Tissue Regenix Group plc (LON:TRX – Get Rating)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 0.58 ($0.01) and traded as high as GBX 0.61 ($0.01). Tissue Regenix Group shares last traded at GBX 0.61 ($0.01), with a volume of 1,663,228 shares.
Tissue Regenix Group Stock Up 0.8 %
The company has a debt-to-equity ratio of 27.60, a current ratio of 4.63 and a quick ratio of 2.36. The stock has a fifty day moving average price of GBX 0.65 and a two-hundred day moving average price of GBX 0.58. The company has a market cap of £42.59 million, a P/E ratio of -6.35 and a beta of 1.53.
Tissue Regenix Group Company Profile
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions.
Read More
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
